Clinical trial
Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
NCT00832689 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
- Lead sponsor
- Yonsei University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- March 31, 2010
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biliary tract cancer